Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Split Virion Vaccine Phase III Trial in ≥3-year-olds
CTR20200715Phase 3Completed
- Sponsor
- Dalian Yalifeng Biopharmaceutical
- Start
- May 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by Dalian Yalifeng Biopharmaceutical. Started May 2020; status: completed.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20200715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200715.